博瑞医药：2025年净利润同比减少70.37%

Core Viewpoint - The company reported a decline in both revenue and net profit for the fiscal year 2025, indicating potential challenges in its financial performance [1] Financial Performance - The company achieved an operating revenue of 1.224 billion yuan, representing a year-on-year decrease of 4.59% [1] - The net profit attributable to shareholders was 56 million yuan, which reflects a significant year-on-year decline of 70.37% [1] - The basic earnings per share were 0.13 yuan, down 71.11% compared to the previous year [1]